Detalhe da pesquisa
1.
Cost-effectiveness analysis of anidulafungin for the treatment of candidaemia and other forms of invasive candidiasis.
BMC Infect Dis
; 15: 463, 2015 Oct 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-26503366
2.
Systematic review and mixed treatment comparison meta-analysis of randomized clinical trials of primary oral antifungal prophylaxis in allogeneic hematopoietic cell transplant recipients.
BMC Infect Dis
; 15: 128, 2015 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-25887385
3.
In vitro activity of aztreonam-avibactam and comparators against Metallo-ß-Lactamase-producing Enterobacterales from ATLAS Global Surveillance Program, 2016-2020.
J Glob Antimicrob Resist
; 36: 123-131, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38154750
4.
Ceftaroline fosamil treatment patterns and outcomes in adults with community-acquired pneumonia: a real-world multinational, retrospective study.
JAC Antimicrob Resist
; 6(3): dlae078, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38803385
5.
Pharmacokinetics of anidulafungin in critically ill patients with candidemia/invasive candidiasis.
Antimicrob Agents Chemother
; 57(4): 1672-6, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23335738
6.
Evaluation of in vitro activity of ceftaroline against pathogens associated with community-acquired pneumonia: ATLAS program 2017-2019.
J Glob Antimicrob Resist
; 33: 360-367, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37187440
7.
Antimicrobial Activities of Aztreonam-Avibactam and Comparator Agents against Enterobacterales Analyzed by ICU and Non-ICU Wards, Infection Sources, and Geographic Regions: ATLAS Program 2016-2020.
Antibiotics (Basel)
; 12(11)2023 Nov 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37998793
8.
In vitro activity of aztreonam/avibactam against isolates of Enterobacterales collected globally from ATLAS in 2019.
J Glob Antimicrob Resist
; 30: 214-221, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35760303
9.
Impact of Underlying Comorbidities on Outcomes of Patients Treated with Ceftaroline Fosamil for Complicated Skin and Soft Tissue Infections: Pooled Results from Three Phase III Randomized Clinical Trials.
Infect Dis Ther
; 11(1): 217-230, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34741280
10.
Treatment outcomes of secondary bacteraemia in patients treated with ceftaroline fosamil: pooled results from six phase III clinical trials.
J Glob Antimicrob Resist
; 28: 108-114, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34922058
11.
Ceftaroline Fosamil for the Empiric Treatment of Hospitalized Adults with cSSTI: An Economic Analysis from the Perspective of the Spanish National Health System.
Clinicoecon Outcomes Res
; 14: 149-161, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35330907
12.
Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation.
Br J Haematol
; 155(3): 318-27, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21880032
13.
Ceftaroline Fosamil for Treatment of Pediatric Complicated Skin and Soft Tissue Infections and Community-Acquired Pneumonia.
Paediatr Drugs
; 23(6): 549-563, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34462863
14.
Baseline Characteristics and Outcomes Among Patients with Complicated Skin and Soft Tissue Infections Admitted to the Intensive Care Unit: Analysis of the Phase 3 COVERS Randomized Trial of Ceftaroline Fosamil Versus Vancomycin Plus Aztreonam.
Infect Dis Ther
; 9(3): 609-623, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32607967
15.
Ceftaroline fosamil as a potential treatment option for Staphylococcus aureus community-acquired pneumonia in adults.
Int J Antimicrob Agents
; 54(4): 410-422, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31404620
16.
Safety and Efficacy of Anidulafungin for Fungal Infection in Patients With Liver Dysfunction or Multiorgan Failure.
Open Forum Infect Dis
; 4(1): ofw241, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28480239
17.
Correction to: Ceftaroline Fosamil for Treatment of Pediatric Complicated Skin and Soft Tissue Infections and Community-Acquired Pneumonia.
Paediatr Drugs
; 23(6): 615, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34617260
18.
Economic Comparison of an Empirical Versus Diagnostic-Driven Strategy for Treating Invasive Fungal Disease in Immunocompromised Patients.
Clin Ther
; 37(6): 1317-1328.e2, 2015 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25891805
19.
Efficacy and safety of anidulafungin in elderly, critically ill patients with invasive Candida infections: a post hoc analysis.
Int J Antimicrob Agents
; 40(6): 521-6, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22998997